Research and development of antischistosomal drugs in the People's Republic of China a 60-year review (Q34125799)

31 July 2017

1 reference

title

Research and development of antischistosomal drugs in the People's Republic of China a 60-year review (English)

1 reference

People's Republic of China

31 July 2017

0 references

5

Jürg Utzinger

0 references

Marcel Tanner

series ordinal

4

object named as

Marcel Tanner

1 reference

31 July 2017

2

Jennifer Keiser

1 reference

31 July 2017

1

Shu-Hua Xiao

1 reference

31 July 2017

3

Ming-Gang Chen

1 reference

31 July 2017

1 January 2010

1 reference

31 July 2017

Advances in Parasitology

1 reference

31 July 2017

73

1 reference

31 July 2017

231-295

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

31 July 2017

1 reference

7 January 2021

Controlling schistosomiasis in Southeast Asia: a tale of two countries

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Treatment of cutaneous leishmaniasis in travelers 2009.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Praziquantel resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Fatal neurotoxicity of arteether and artemether

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Chemotherapy of schistosomiasis: present and future

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Use of praziquantel for clinical treatment and morbidity control of schistosomiasis japonica in China: a review of 30 years' experience

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Schistosomiasis control in China

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Praziquantel: is there real resistance and are there alternatives?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

1 reference

7 January 2021

Antischistosomal drugs: past, present ... and future?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Toxicity of the antimalarial artemisinin and its dervatives.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Schistosomiasis: challenges for control, treatment and drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Drugs for the control of parasitic diseases: current status and development in schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Decision-model estimation of the age-specific disability weight for schistosomiasis japonica: a systematic review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Praziquantel, a new broad-spectrum antischistosomal agent

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Assessment of the age-specific disability weight of chronic schistosomiasis japonica

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Artemisinins and synthetic trioxolanes in the treatment of helminth infections

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

The synthetic peroxide OZ78 is effective against Echinostoma caproni and Fasciola hepatica

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Clonorchicidal properties of the synthetic trioxolane OZ78.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Mefloquine--an aminoalcohol with promising antischistosomal properties in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Activity of artemether and mefloquine against juvenile and adult Schistosoma mansoni in athymic and immunocompetent NMRI mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Asymmetries of poverty: why global burden of disease valuations underestimate the burden of neglected tropical diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

The unacknowledged impact of chronic schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

CHEMOTHERAPY OF EXPERIMENTAL SCHISTOSOMA MANSONI INFECTIONS WITH A NITRO-THIAZOLE DERIVATIVE, CIBA 32,644-BA

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

A double-blind field trial on the effects of artemether on Schistosoma japonicum infection in a highly endemic focus in southern China

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Schistosomiasis in China

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

A review of the epidemiology of schistosomiasis japonica in China.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Schistosoma mekongi in Cambodia and Lao People's Democratic Republic

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Antimalarials. 7. Bis(trifluoromethyl)-.alpha.-(2-piperidyl)-4-quinolinemethanols

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Schistosoma mansoni: chemotherapy of infections of different ages

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

4-Isothiocyanato-4'-nitrodiphenylamine (C 9333-Go/CGP 4540), an anthelminthic with an unusual spectrum of activity against intestinal nematodes, filariae and schistosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

From discovery to eradication of schistosomiasis in Japan: 1847-1996.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Effect of combined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Current progress in the development and use of artemether for chemoprophylaxis of major human schistosome parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

The potential of artemether for the control of schistosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Conquering schistosomiasis in China: the long march

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Identification of an antimalarial synthetic trioxolane drug development candidate

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Comparison of morphology, pathogenicity and drug response among three isolates of Schistosoma japonicum in the mainland of China

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Schistosomiasis control: experiences and lessons from China.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

A strategy to control transmission of Schistosoma japonicum in China

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Qinghaosu (Artemisinin): The Price of Success

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Stability and reproductive fitness of Schistosoma mansoni isolates with decreased sensitivity to praziquantel

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Development of antischistosomal drugs in China, with particular consideration to praziquantel and the artemisinins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Histopathological alteration of juvenile Schistosoma japonicum in mice following treatment with single-dose mefloquine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Quantitative determination of praziquantel in serum by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Praziquantel-induced vesicle formation in the tegument of male Schistosoma mansoni is calcium dependent

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

The prophylactic effects of artemether against Schistosoma japonicum infections

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Effect of praziquantel together with artemether on Schistosoma japonicum parasites of different ages in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Artemether administered together with haemin damages schistosomes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Schistosoma japonicum: effect of artemether on glutathione S-transferase and superoxide dismutase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Schistosoma japonicum: In vitro effects of artemether combined with haemin depend on cultivation media and appraisal of artemether products appearing in the media

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Further study on mefloquine concerning several aspects in experimental treatment of mice and hamsters infected with Schistosoma japonicum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

The in vitro effect of mefloquine and praziquantel against juvenile and adult Schistosoma japonicum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Effect of single-dose oral mefloquine on the morphology of adult Schistosoma japonicum in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Transmission electron microscopic observation on ultrastructural alterations in Schistosoma japonicum caused by mefloquine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Efficacy of praziquantel against Schistosoma japonicum: field evaluation in an area with repeated chemotherapy compared with a newly identified endemic focus in Hunan, China

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Histopathological changes in adult Schistosoma japonicum harbored in mice treated with a single dose of mefloquine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

The public health significance and control of schistosomiasis in China--then and now.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Schistosomiasis japonica control and research needs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

Potential long-term toxicity of repeated orally administered doses of artemether in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0065-308X%2810%2973009-8

7 January 2021

10.1016/S0065-308X(10)73009-8

Identifiers

DOI

1 reference

release_lc5xoc5xq5dd5felhknmcc2vki

31 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lc5xoc5xq5dd5felhknmcc2vki

24 November 2022

mapped directly with Wikidata item

PubMed ID

20627145

1 reference

PubMed ID

20627145